Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bladder Cancer
Reports outline bladder cancer study results from E. Schiffer et al
April 1st, 2008
" Bladder cancer (BCa) is one of the most prevalent malignancies worldwide, mostly due to its high recurrence rates. In consequence, the necessity of repeated screening for reappearance demonstrates the urgent need for novel biomarkers as alternatives to invasive standard procedures," scientists writing in the World Journal of Urology report. " Proteomic technologies have emerged as powerful platforms for unbiased biomarker discovery and revolutionized the classical ''target-driven'' analysis of single marker candidates. Although proteome profiling is still far from demonstrating its full potential in clinical diagnosis, first studies clearly denote its...
Source: Cancer Weekly (2008-04-01)
|
